1Ollenschlager G, Kopp I, Lelgemann M. The German Program for Disease Management Guidelines: COPD Guideline 2006 [J]. MedKlin (Munich), 2007, 102 (1): 50-55.
2Dahl R, Greefhorst LA, Nowak D, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2001, 164 (5): 778-784.
3Goldkorn A, Diotto P, Burgess C, et al. The pulmonary and extra-pulmonary efects of high-dose formoterol in COPD: a comparison with salbutamol [J]. Respirology, 2004, 9 (1) : 102-108.
4Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, lacebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol [J] . Chest, 2002, 122 (1): 47-55.
5Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD [J]. Eur Respir J, 2008, 31 (4) : 742-750
7Culpitt SV, de Matos C, Russell RE, et al. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in COPD [J]. Am J Respir Crit Care Med, 2002, 165 (10): 1371 - 1376.
8Kobayashi M, Nasuhara Y, Betsuyaku T, et al. Effect of lowdose theophylline on airway inflammation in COPD [J]. Respirology, 2004, 9 (2): 249-254.
9Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression [J]. Proc Natl Acad Sci USA, 2002, 99 (13): 8921 - 8926.
10Ito K, Lim S, Chung KF, Barnes PJ, et al. Theophylline enhances histone deacetylase activity and restores glucocorticoid function during oxidative stress [J]. Am J Respir Crit Care Med, 2002, 165: A625.
二级参考文献15
1Scanlon PD,Connett JE,Waller LA,et al.Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease.The Lung Health Study.Am J Respir Crit Care Med,2000,161(2 Pt 1):381-390.
2British Thoracic Society.BTS guidelines for the management of chronic obstructive pulmonary disease.The COPD Guidelines Group of the Standards of Care Committee of the BTS.Thorax,1997,52Suppl 5:S1-S28.
3Sullivan P,Bekir S,Jaffar Z,et al.Anti-inflammatory effects of lowdose oral theophylline in atopic asthma.Lancet,1994,343:1006-1008.
4Zheng J,Zhong N.Normative values of pulmonary function testing in Chinese adults.Chin Med J(Engl),2002,115:50-54.
5Anthonisen NR,Manfreda J,Warren CP,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.Ann Intern Med,1987,106:196-204.
6Seemungal TA,Donaldson GC,Bhowmik A,et al.Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2000,161:1608-1613.
7Jenne JW.What role for theophylline? Thorax,1994,49:97-100.
8Kidney J,Dominguez M,Taylor PM,et al.Immunomodulation by theophylline in asthma.Demonstration by withdrawal of therapy.Am J Respir Crit Care Med,1995,151:1907-1914.
9Culpitt SV,de Matos C,Russell RE,et al.Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2002,165:1371-1376.
10Tsukagoshi H,Shimizu Y,Iwamae S,et al.Evidence of oxidative stress in asthma and COPD:potential inhibitory effect of theophylline.Respir Med,2000,94:584-588.
